46-60 of 74
The Road Ahead: What's on the Horizon for FCS and SHTG Management
MinuteCE®The Road Ahead: What's on the Horizon for FCS and SHTG Management
Pam R. Taub, MD, FACC, FASPC
Prof. Kausik Ray
Harry Yoon, MD
Jaffer Ajani, MD
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
MinuteCE®Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
Jaffer Ajani, MD
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
MinuteCE®The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
Harry Yoon, MD
Effective Monitoring and Management of Adverse Effects in Metastatic ESCC
MinuteCE®Effective Monitoring and Management of Adverse Effects in Metastatic ESCC
Harry Yoon, MD
Jaffer Ajani, MD
ICI Combination Regimens for First-Line Treatment of Metastatic ESCC
MinuteCE®ICI Combination Regimens for First-Line Treatment of Metastatic ESCC
Harry Yoon, MD
Jaffer Ajani, MD
- advertisement
Strategies for Navigating First-Line Treatment Selection in Metastatic ESCC
MinuteCE®Strategies for Navigating First-Line Treatment Selection in Metastatic ESCC
Harry Yoon, MD
Jaffer Ajani, MD
Tailoring First-Line Regimens: Patient-Centric Selection in Metastatic ESCC
MinuteCE®Tailoring First-Line Regimens: Patient-Centric Selection in Metastatic ESCC
Harry Yoon, MD
Jaffer Ajani, MD
The Impact of First-Line Treatment on Subsequent Treatment Options for Metastatic ESCC
MinuteCE®The Impact of First-Line Treatment on Subsequent Treatment Options for Metastatic ESCC
Harry Yoon, MD
Jaffer Ajani, MD
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
CME/CEAdvances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Naim Alkhouri, MD, FAASLD, DABOM
Advances in the Treatment and Management of MASH: More Options, More Decisions
CME/CE Broadcast ReplayAdvances in the Treatment and Management of MASH: More Options, More Decisions
Mary E. Rinella, MD, FAASLD
Naga Chalasani, MD, FAASLD
Mazen Noureddin, MD, MHSc
Practical Management of Variceal Bleeding and Hepatorenal Syndrome
CME/CEPractical Management of Variceal Bleeding and Hepatorenal Syndrome
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Andrew Keaveny, MD
Don Rockey, MD
- advertisement
Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG
Marlyn Mayo, MD
Atoosa Rabiee, MD
Primary Biliary Cholangitis: The Phenotype, It Is a Changin'
MinuteCE®Primary Biliary Cholangitis: The Phenotype, It Is a Changin'
Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG
Atoosa Rabiee, MD
Primary Biliary Cholangitis vs Primary Sclerosing Cholangitis: Do You Know the Difference?
MinuteCE®Primary Biliary Cholangitis vs Primary Sclerosing Cholangitis: Do You Know the Difference?
Marlyn Mayo, MD
Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG
